Zelira Therapeutics Ltd has released a press release.
Australian Regulators Approve Zelda Insomnia Clinical Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Successful Results in Autism Observation Trial
- Expansion of Breast Cancer Research Collaboration
- Zelda Enters into Strategic Agreement with Knop Laboratories
- Positive Results From Pre-Clinical Breast Cancer Studies
- March 2017 Quarterly Report
Later from Zelira Therapeutics
- Zelda joins with US Childrens Hospital for autism study
- Appendix 4D & FY18 Interim Financial Report
- Expansion of Pancreatic Cancer Research Programme
- Insomnia Clinical Trial Update-Patient Recruitment Completed
- March 2018 Quarterly Report
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics